Independent Wealth Network Inc. reduced its holdings in shares of iShares Biotechnology ETF (NASDAQ:IBB – Free Report) by 5.5% in the second quarter, according to its most recent filing with the SEC. The fund owned 3,249 shares of the financial services provider’s stock after selling 190 shares during the period. Independent Wealth Network Inc.’s holdings in iShares Biotechnology ETF were worth $413,000 at the end of the most recent quarter.
A number of other institutional investors and hedge funds have also recently modified their holdings of IBB. Vontobel Holding Ltd. grew its stake in iShares Biotechnology ETF by 9.5% in the first quarter. Vontobel Holding Ltd. now owns 5,060 shares of the financial services provider’s stock worth $659,000 after purchasing an additional 440 shares in the last quarter. Blair William & Co. IL lifted its stake in iShares Biotechnology ETF by 9.7% in the first quarter. Blair William & Co. IL now owns 18,717 shares of the financial services provider’s stock worth $2,439,000 after acquiring an additional 1,659 shares during the period. NewEdge Advisors LLC lifted its stake in iShares Biotechnology ETF by 11.7% in the first quarter. NewEdge Advisors LLC now owns 13,777 shares of the financial services provider’s stock worth $1,796,000 after acquiring an additional 1,445 shares during the period. DCF Advisers LLC purchased a new stake in iShares Biotechnology ETF in the first quarter worth about $912,000. Finally, Laurel Wealth Advisors Inc. lifted its stake in iShares Biotechnology ETF by 22.6% in the first quarter. Laurel Wealth Advisors Inc. now owns 3,019 shares of the financial services provider’s stock worth $393,000 after acquiring an additional 557 shares during the period. 69.61% of the stock is owned by institutional investors.
iShares Biotechnology ETF Stock Performance
NASDAQ:IBB traded down $0.38 during trading hours on Tuesday, reaching $124.87. The company’s stock had a trading volume of 365,441 shares, compared to its average volume of 1,512,161. iShares Biotechnology ETF has a 12 month low of $113.37 and a 12 month high of $138.74. The stock has a 50 day moving average price of $128.05 and a two-hundred day moving average price of $129.30.
About iShares Biotechnology ETF
iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ.
- Five stocks we like better than iShares Biotechnology ETF
- What is a Stock Market Index and How Do You Use Them?
- Virtual Riches: 3 Stocks Leading the VR Revolution
- Investing in Blue-Chip Stocks
- 5 eCommerce Companies that need to be on Your Watch List
- Best Stocks Under $10.00
- 2 Beauty Stocks Beaten By the Ugly Stick But Ready to Rally
Receive News & Ratings for iShares Biotechnology ETF Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for iShares Biotechnology ETF and related companies with MarketBeat.com's FREE daily email newsletter.